Literature DB >> 11560793

Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?

M A Ortner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560793     DOI: 10.1007/s11894-001-0075-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


× No keyword cloud information.
  28 in total

1.  Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus.

Authors:  M Panjehpour; B F Overholt; T Vo-Dinh; R C Haggitt; D H Edwards; F P Buckley
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

Review 2.  Barrett's esophagus. A review of the pathologist's role in diagnosis and management.

Authors:  R E Petras; M V Sivak; T W Rice
Journal:  Pathol Annu       Date:  1991

3.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.

Authors:  B F Overholt; M Panjehpour; J M Haydek
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

4.  Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.

Authors:  P Rozen; M Baratz; F Fefer; T Gilat
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

5.  Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus.

Authors:  J E McArdle; K J Lewin; G Randall; W Weinstein
Journal:  Hum Pathol       Date:  1992-05       Impact factor: 3.466

Review 6.  Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.

Authors:  H Barr
Journal:  Gastrointest Endosc Clin N Am       Date:  2000-07

7.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.

Authors:  R Ackroyd; N J Brown; M F Davis; T J Stephenson; S L Marcus; C J Stoddard; A G Johnson; M W Reed
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

8.  Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.

Authors:  J L Van Laethem; M Cremer; M O Peny; M Delhaye; J Devière
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

9.  High-grade dysplasia in the columnar-lined esophagus.

Authors:  N K Altorki; M Sunagawa; A G Little; D B Skinner
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence.

Authors:  W Polkowski; J J van Lanschot; F J Ten Kate; J P Baak; G N Tytgat; H Obertop; W J Voorn; G J Offerhaus
Journal:  Surg Oncol       Date:  1995-06       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.